Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders.
Invea Therapeutics has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Invea Therapeutics is headquartered in Guilford, United States.
Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders.
Invea Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Invea Therapeutics — Funding & Investors." VCBacked, April 22, 2022, https://www.vcbacked.co/company/invea-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Invea Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/invea-therapeutics
{{cite web |title=Invea Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/invea-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated